Research Papers:
2L-PCA: a two-level principal component analyzer for quantitative drug design and its applications
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1942 views | HTML 2544 views | ?
Abstract
Qi-Shi Du1,4,*, Shu-Qing Wang2,*, Neng-Zhong Xie1,*, Qing-Yan Wang1, Ri-Bo Huang1 and Kuo-Chen Chou3,4
1State Key Laboratory of China for Biomass Energy Enzyme Technology, National Engineering Research Center of China for Non-Food Biorefinery, Guangxi Academy of Sciences, Nanning 530007, China
2School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
3Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
4Gordon Life Science Institute, Boston, MA 02478, USA
*These authors have contributed equally to this work
Correspondence to:
Qi-Shi Du, email: [email protected]
Kuo-Chen Chou, email: [email protected]
Keywords: drug design, PCA, molecular fragments, physicochemical properties, peptides
Received: April 26, 2017 Accepted: June 30, 2017 Published: August 01, 2017
ABSTRACT
A two-level principal component predictor (2L-PCA) was proposed based on the principal component analysis (PCA) approach. It can be used to quantitatively analyze various compounds and peptides about their functions or potentials to become useful drugs. One level is for dealing with the physicochemical properties of drug molecules, while the other level is for dealing with their structural fragments. The predictor has the self-learning and feedback features to automatically improve its accuracy. It is anticipated that 2L-PCA will become a very useful tool for timely providing various useful clues during the process of drug development.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19757